Literature DB >> 16302871

Epidemiology of idiopathic generalized epilepsies.

Pierre Jallon1, Patrick Latour.   

Abstract

Idiopathic generalized epilepsies (IGEs) are a relatively new category of disorders defined by strict clinical and electroencephalogram (EEG) features proposed by the International League Against Epilepsy (ILAE) classification of epileptic syndromes. IGEs are usually easy to diagnose when clinical and EEG data are collected, but epilepsy is not synonymous with epileptic syndrome. So far, IGEs are studied in the large group of epilepsies of undetermined or unknown etiology although the genetic origin is now largely accepted. ILAE-proposed criteria are helpful in the clinical and therapeutic management of IGEs, but many epidemiologic studies still confuse the cryptogenic and idiopathic groups. Some syndromes in childhood, which are completely described by strict electroclinical criteria such as the absence epilepsies, juvenile myoclonic epilepsies, are usually included and analyzed in epidemiologic studies; however, other epileptic syndromes observed in infancy, such as benign familial neonatal seizures and benign myoclonic epilepsy in infancy, are quite rare and are usually excluded from epidemiologic surveys because they are difficult to describe completely in electro-clinical terms. Another strong limitation in the study of epidemiology of IGEs is the lack of EEG data, either because EEG is not available or the routine EEG is normal. This is particularly relevant in the inclusion of patients with only tonic-clonic seizures. IGEs encompass several different syndromes, and a few patients shift from one phenotype to another. The overlapping of some syndromes during infancy and adolescence increased the difficulty to individualize strictly the correct syndrome. Many discrepancies can be observed in the distribution of the different syndromes included in the group of IGEs, because the strict criteria for classifying these syndromes proposed by the ILAE are often not respected. With this understanding, the general frequency of IGEs can be assessed at 15-20% of all epilepsies. The frequency and the distribution of incidence and prevalence of the different syndromes are tentatively reported and discussed. When the term idiopathic is used following the restrictive ILAE criteria, the mortality data concerning patients with idiopathic epilepsies do not show an increased standardized mortality ratio.

Entities:  

Mesh:

Year:  2005        PMID: 16302871     DOI: 10.1111/j.1528-1167.2005.00309.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  70 in total

1.  NIPA2 located in 15q11.2 is mutated in patients with childhood absence epilepsy.

Authors:  Yuwu Jiang; Yuehua Zhang; Pingping Zhang; Tian Sang; Feng Zhang; Taoyun Ji; Qionghui Huang; Han Xie; Renqian Du; Bin Cai; Haijuan Zhao; Jingmin Wang; Ye Wu; Husheng Wu; Keming Xu; Xiaoyan Liu; Piu Chan; Xiru Wu
Journal:  Hum Genet       Date:  2012-02-26       Impact factor: 4.132

2.  Association study of the 2-bp deletion polymorphism in exon 6 of the CHRFAM7A gene with idiopathic generalized epilepsy.

Authors:  Agata Rozycka; Jolanta Dorszewska; Barbara Steinborn; Margarita Lianeri; Anna Winczewska-Wiktor; Aleksandra Sniezawska; Kamila Wisniewska; Pawel P Jagodzinski
Journal:  DNA Cell Biol       Date:  2013-09-11       Impact factor: 3.311

Review 3.  Copy number variants are frequent in genetic generalized epilepsy with intellectual disability.

Authors:  Saul A Mullen; Gemma L Carvill; Susannah Bellows; Marta A Bayly; Holger Trucks; Dennis Lal; Thoman Sander; Samuel F Berkovic; Leanne M Dibbens; Ingrid E Scheffer; Heather C Mefford
Journal:  Neurology       Date:  2013-09-25       Impact factor: 9.910

4.  Familial cosegregation of rare genetic variants with disease in complex disorders.

Authors:  Ingo Helbig; Susan E Hodge; Ruth Ottman
Journal:  Eur J Hum Genet       Date:  2012-09-26       Impact factor: 4.246

Review 5.  Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.

Authors:  Anna Serafini; Elizabeth Gerard; Pierre Genton; Arielle Crespel; Philippe Gelisse
Journal:  CNS Drugs       Date:  2019-03       Impact factor: 5.749

Review 6.  Defects at the crossroads of GABAergic signaling in generalized genetic epilepsies.

Authors:  Jing-Qiong Kang
Journal:  Epilepsy Res       Date:  2017-08-26       Impact factor: 3.045

7.  Investigation of glutamine and GABA levels in patients with idiopathic generalized epilepsy using MEGAPRESS.

Authors:  Fahmida A Chowdhury; Ruth L O'Gorman; Lina Nashef; Robert D Elwes; Richard A Edden; James B Murdoch; Gareth J Barker; Mark P Richardson
Journal:  J Magn Reson Imaging       Date:  2014-03-03       Impact factor: 4.813

8.  Epilepsy in families: Age at onset is a familial trait, independent of syndrome.

Authors:  Colin A Ellis; Leonid Churilov; Michael P Epstein; Sharon X Xie; Susannah T Bellows; Ruth Ottman; Samuel F Berkovic
Journal:  Ann Neurol       Date:  2019-05-20       Impact factor: 10.422

9.  Therapeutic Outcomes and Prognostic Factors in Childhood Absence Epilepsy.

Authors:  Hye Ryun Kim; Gun Ha Kim; So Hee Eun; Baik Lin Eun; Jung Hye Byeon
Journal:  J Clin Neurol       Date:  2015-11-26       Impact factor: 3.077

10.  Thalamofrontal circuitry and executive dysfunction in recent-onset juvenile myoclonic epilepsy.

Authors:  Dalin T Pulsipher; Michael Seidenberg; Leslie Guidotti; Victoria N Tuchscherer; Jared Morton; Raj D Sheth; Bruce Hermann
Journal:  Epilepsia       Date:  2009-01-17       Impact factor: 5.864

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.